CNS Pharmaceuticals, Inc. Basic Shares Outstanding (Weighted Average)
CNS Pharmaceuticals, Inc. (CNSP) reported Basic Shares Outstanding (Weighted Average) of 6.84 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-12
- CNS Pharmaceuticals, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 6.84M shares, a 1747.53% increase year-over-year.
- CNS Pharmaceuticals, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 676.17K shares, a 197.58% increase year-over-year.
- CNS Pharmaceuticals, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 613.83K shares, a 585.70% increase year-over-year.
- CNS Pharmaceuticals, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 558.87K shares, a 1427.25% increase year-over-year.
- CNS Pharmaceuticals, Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 443.37K shares, a 1293.23% increase from fiscal 2024.
- CNS Pharmaceuticals, Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 31.82K shares, a 2011.68% increase from fiscal 2023.
- CNS Pharmaceuticals, Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 1.51K shares, a 99.89% decline from fiscal 2022.
- CNS Pharmaceuticals, Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 1.36M shares, a 55.02% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 6.84M shares 10-Q · filed 2026-08-12 | 3.77M shares 10-Q · filed 2026-08-12 | 2.71M shares derived: average of 3 quarters · filed 2026-08-12 | 2.17M shares derived: average of 4 quarters · filed 2026-08-12 | ||||
| 2026-03-31 | 676.17K shares 10-Q · filed 2026-05-14 | 645.00K shares derived: average of 2 quarters · filed 2026-05-14 | 616.29K shares derived: average of 3 quarters · filed 2026-05-14 | 554.75K shares derived: average of 4 quarters · filed 2026-08-12 | ||||
| 2025-12-31 | 613.83K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | 586.35K shares derived: average of 2 quarters · filed 2026-03-31 | 514.28K shares derived: average of 3 quarters · filed 2026-08-12 | 443.37K shares 10-K · filed 2026-03-31 | ||||
| 2025-09-30 | 558.87K shares 10-Q · filed 2025-11-14 | 464.50K shares derived: average of 2 quarters · filed 2026-08-12 | 386.55K shares 10-Q · filed 2025-11-14 | 311.43K shares derived: average of 4 quarters · filed 2026-08-12 | ||||
| 2025-06-30 | 370.13K shares 10-Q · filed 2026-08-12 | 298.78K shares 10-Q · filed 2026-08-12 | 228.96K shares derived: average of 3 quarters · filed 2026-08-12 | 180.86K shares derived: average of 4 quarters · filed 2026-08-12 | ||||
| 2025-03-31 | 227.22K shares 10-Q · filed 2026-05-14 | 2.73M shares 10-Q · filed 2025-05-15 | 158.37K shares derived: average of 2 quarters · filed 2026-05-14 | 117.78K shares derived: average of 3 quarters · filed 2026-05-14 | 88.49K shares derived: average of 4 quarters · filed 2026-05-14 | |||
| 2024-12-31 | 89.52K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | 63.06K shares derived: average of 2 quarters · filed 2026-03-31 | 42.25K shares derived: average of 3 quarters · filed 2026-03-31 | 31.82K shares 10-K · filed 2026-03-31 | 382.24K shares 10-K · filed 2025-03-31 | |||
| 2024-09-30 | 36.59K shares 10-Q · filed 2025-11-14 | 22.18M shares 10-Q · filed 2024-11-14 | 18.61K shares derived: average of 2 quarters · filed 2025-11-14 | 12.59K shares 10-Q · filed 2025-11-14 | 7.58M shares 10-Q · filed 2024-11-14 | -38.23K shares derived: average of 4 quarters · filed 2025-11-14 | ||
| 2024-06-30 | 625.00 shares 10-Q · filed 2025-08-14 | 376.64K shares 10-Q · filed 2024-08-14 | 457.00 shares 10-Q · filed 2025-08-14 | 275.11K shares 10-Q · filed 2024-08-14 | -63.18K shares derived: average of 3 quarters · filed 2025-08-14 | -26.50K shares derived: average of 4 quarters · filed 2025-08-14 | ||
| 2024-03-31 | 3.47K shares 10-Q · filed 2025-05-15 | 8.71M shares 10-Q · filed 2024-05-15 | -95.08K shares derived: average of 2 quarters · filed 2025-05-15 | -35.54K shares derived: average of 3 quarters · filed 2025-05-15 | -7.27K shares derived: average of 4 quarters · filed 2025-05-15 | |||
| 2023-12-31 | -193.63K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -55.04K shares derived: average of 2 quarters · filed 2025-03-31 | -10.85K shares derived: average of 3 quarters · filed 2025-03-31 | 1.51K shares 10-K · filed 2025-03-31 | 3.77M shares 10-K · filed 2024-04-01 | |||
| 2023-09-30 | 83.54K shares 10-Q · filed 2024-11-14 | 4.18M shares 10-Q · filed 2023-11-14 | 80.54K shares derived: average of 2 quarters · filed 2024-11-14 | 66.55K shares 10-Q · filed 2024-11-14 | 3.33M shares 10-Q · filed 2023-11-14 | 887.83K shares derived: average of 4 quarters · filed 2024-11-14 | ||
| 2023-06-30 | 77.55K shares 10-Q · filed 2024-08-14 | 3.88M shares 10-Q · filed 2023-08-14 | 57.87K shares 10-Q · filed 2024-08-14 | 2.89M shares 10-Q · filed 2023-08-14 | 1.16M shares derived: average of 3 quarters · filed 2024-08-14 | 1.20M shares derived: average of 4 quarters · filed 2024-08-14 | ||
| 2023-03-31 | 1.91M shares 10-Q · filed 2024-05-15 | 1.70M shares derived: average of 2 quarters · filed 2024-05-15 | 1.57M shares derived: average of 3 quarters · filed 2024-05-15 | 1.51M shares derived: average of 4 quarters · filed 2024-05-15 | ||||
| 2022-12-31 | 1.48M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | 1.41M shares derived: average of 2 quarters · filed 2024-04-01 | 1.38M shares derived: average of 3 quarters · filed 2024-04-01 | 1.36M shares 10-K · filed 2024-04-01 | ||||
| 2022-09-30 | 1.33M shares 10-Q · filed 2023-11-14 | 40.03M shares 10-Q · filed 2022-11-10 | 1.33M shares derived: average of 2 quarters · filed 2023-11-14 | 1.32M shares 10-Q · filed 2023-11-14 | 39.63M shares 10-Q · filed 2022-11-10 | -17.52M shares derived: average of 4 quarters · filed 2023-11-14 | ||
| 2022-06-30 | 1.33M shares 10-Q · filed 2023-08-14 | 40.03M shares 10-Q · filed 2022-08-12 | 1.31M shares 10-Q · filed 2023-08-14 | 39.43M shares 10-Q · filed 2022-08-12 | -23.81M shares derived: average of 3 quarters · filed 2023-08-14 | -11.00M shares derived: average of 4 quarters · filed 2023-08-14 | ||
| 2022-03-31 | 1.29M shares 10-Q · filed 2023-05-15 | -36.38M shares derived: average of 2 quarters · filed 2023-05-15 | -15.11M shares derived: average of 3 quarters · filed 2023-05-15 | -4.97M shares derived: average of 4 quarters · filed 2023-05-15 | ||||
| 2021-12-31 | -74.06M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -23.31M shares derived: average of 2 quarters · filed 2023-03-31 | -7.06M shares derived: average of 3 quarters · filed 2023-03-31 | 878.44K shares 10-K · filed 2023-03-31 | ||||
| 2021-09-30 | 27.44M shares 10-Q · filed 2022-11-10 | 26.44M shares derived: average of 2 quarters · filed 2022-11-10 | 25.86M shares 10-Q · filed 2022-11-10 | |||||
| 2021-06-30 | 25.43M shares 10-Q · filed 2022-08-12 | 25.06M shares 10-Q · filed 2022-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |